Artivion | CRY - Assets


Artivion reported $884.8M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Accuray USD 456.82M 13.42M Sep/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Artivion USD 884.8M 27.13M Dec/2025
AtriCure USD 654.18M 18.74M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
Inogen USD 307.01M 5.03M Sep/2025
Integra LifeSciences USD 3.6B 44.45M Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Orthofix International USD 850.65M 18.04M Dec/2025
Pfizer USD 208.73B 2.64B Sep/2025
ResMed USD 8.5B 195.02M Dec/2025
Stryker USD 47.84B 787M Dec/2025
Surmodics USD 169.82M 8.74M Jun/2025
Tandem Diabetes Care USD 881.11M 6.46M Dec/2025
Teleflex USD 6.95B 924.7M Dec/2025
Terumo JPY 2.26T 362.12B Dec/2025
Trinity Biotech USD 103.71M 4.08M Sep/2025